Edap Tms S.A. (EDAP) Cut to Sell at ValuEngine

ValuEngine cut shares of Edap Tms S.A. (NASDAQ:EDAP) from a hold rating to a sell rating in a report issued on Friday morning.

Several other analysts have also recently issued reports on the company. Zacks Investment Research upgraded Edap Tms from a strong sell rating to a hold rating in a research note on Wednesday, October 25th. HC Wainwright reiterated a buy rating and issued a $6.50 price objective on shares of Edap Tms in a research note on Monday, October 9th.

Shares of Edap Tms (NASDAQ:EDAP) traded down $0.01 during midday trading on Friday, hitting $2.92. The stock had a trading volume of 26,100 shares, compared to its average volume of 74,368. The firm has a market capitalization of $84.67, a PE ratio of 73.00 and a beta of 1.05. The company has a debt-to-equity ratio of 0.11, a quick ratio of 2.35 and a current ratio of 2.96. Edap Tms has a twelve month low of $2.25 and a twelve month high of $3.85.

Edap Tms (NASDAQ:EDAP) last announced its quarterly earnings data on Wednesday, August 23rd. The medical equipment provider reported ($0.05) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.02) by ($0.03). The company had revenue of $10.40 million during the quarter, compared to analyst estimates of $10.00 million. Edap Tms had a negative net margin of 0.27% and a positive return on equity of 10.31%. The firm’s revenue was up 13.0% on a year-over-year basis. During the same quarter in the previous year, the business posted $0.10 earnings per share. sell-side analysts expect that Edap Tms will post -0.04 earnings per share for the current fiscal year.

ILLEGAL ACTIVITY NOTICE: “Edap Tms S.A. (EDAP) Cut to Sell at ValuEngine” was reported by Chaffey Breeze and is the sole property of of Chaffey Breeze. If you are accessing this piece on another domain, it was illegally copied and reposted in violation of United States and international copyright law. The original version of this piece can be viewed at https://www.chaffeybreeze.com/2017/11/13/edap-tms-s-a-edap-cut-to-sell-at-valuengine.html.

Several hedge funds and other institutional investors have recently made changes to their positions in EDAP. Archon Capital Management LLC acquired a new stake in shares of Edap Tms in the second quarter valued at $2,474,000. Essex Investment Management Co. LLC raised its stake in shares of Edap Tms by 520.2% in the third quarter. Essex Investment Management Co. LLC now owns 323,528 shares of the medical equipment provider’s stock valued at $964,000 after acquiring an additional 271,367 shares in the last quarter. Virtu KCG Holdings LLC acquired a new stake in shares of Edap Tms in the second quarter valued at $117,000. Finally, Hilton Capital Management LLC raised its stake in Edap Tms by 43.1% in the second quarter. Hilton Capital Management LLC now owns 83,000 shares of the medical equipment provider’s stock valued at $274,000 after buying an additional 25,000 shares in the last quarter. Institutional investors and hedge funds own 10.17% of the company’s stock.

About Edap Tms

EDAP TMS SA (EDAP) is a holding company engaged in developing and marketing the Ablatherm and Focal One devices. The Company operates two divisions: High Intensity Focused Ultrasound (HIFU) and Urology Devices and Services (UDS) (including lithotripsy activities). The Company is developing HIFU technology for the treatment of certain other types of tumors.

To view ValuEngine’s full report, visit ValuEngine’s official website.

Receive News & Ratings for Edap Tms S.A. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Edap Tms S.A. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply